Services Doctors Medicines For doctors Blog Help

en

en

Background pattern

Background pattern

Medicines with Recombinant fusion protein NHBA of Neisseria meningitidis group B in Spain

Filters

Filter by letter

Filters

B

Bexsero suspension inyectable en jeringa precargada

Dosage form: Suspension for injection, 50 µg/50 µg/50 µg/25 µg

Active substance: Recombinant fusion protein NHBA of Neisseria meningitidis group B, Recombinant protein NadA of Neisseria meningitidis group B, Recombinant fusion protein FHbp of Neisseria meningitidis group B, Outer membrane vesicles (OMV) of Neisseria meningitidis group B (strain NZ98/254, measured as total protein containing PorA P1.4)

Manufacturer: Glaxosmithkline Vaccines S.R.L.

Prescription required

Search